ATE302770T1 - Benzimidazolverbindungen die nociceptinrezeptoraffinität haben - Google Patents
Benzimidazolverbindungen die nociceptinrezeptoraffinität habenInfo
- Publication number
- ATE302770T1 ATE302770T1 AT00980981T AT00980981T ATE302770T1 AT E302770 T1 ATE302770 T1 AT E302770T1 AT 00980981 T AT00980981 T AT 00980981T AT 00980981 T AT00980981 T AT 00980981T AT E302770 T1 ATE302770 T1 AT E302770T1
- Authority
- AT
- Austria
- Prior art keywords
- nociceptine
- receptor affinity
- benzimidazole compounds
- compounds
- affinity
- Prior art date
Links
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- 208000002193 Pain Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- 208000005298 acute pain Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 108010020615 nociceptin receptor Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16939499P | 1999-12-06 | 1999-12-06 | |
| PCT/US2000/033019 WO2001039775A1 (en) | 1999-12-06 | 2000-12-06 | Benzimidazole compounds having nociceptin receptor affinity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE302770T1 true ATE302770T1 (de) | 2005-09-15 |
Family
ID=22615490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00980981T ATE302770T1 (de) | 1999-12-06 | 2000-12-06 | Benzimidazolverbindungen die nociceptinrezeptoraffinität haben |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7456198B2 (de) |
| EP (1) | EP1242085B1 (de) |
| JP (2) | JP2003524634A (de) |
| AT (1) | ATE302770T1 (de) |
| AU (1) | AU1816901A (de) |
| DE (1) | DE60022226D1 (de) |
| HK (1) | HK1049284B (de) |
| WO (1) | WO2001039775A1 (de) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003524634A (ja) * | 1999-12-06 | 2003-08-19 | ユーロ−セルティーク,エス.エイ. | ノシセプチン受容体親和性を有するベンズイミダゾール化合物 |
| ATE410165T1 (de) * | 2001-04-18 | 2008-10-15 | Euro Celtique Sa | Nociceptin-analoga |
| WO2003037890A2 (en) * | 2001-11-01 | 2003-05-08 | Icagen, Inc. | Piperidines |
| US7566728B2 (en) | 2002-03-29 | 2009-07-28 | Mitsubishi Tanabe Pharma Corporation | Remedy for sleep disturbance |
| JP2005289816A (ja) * | 2002-05-14 | 2005-10-20 | Banyu Pharmaceut Co Ltd | ベンズイミダゾール誘導体 |
| DE10252666A1 (de) * | 2002-11-11 | 2004-08-05 | Grünenthal GmbH | N-Piperidyl-cyclohexan-Derivate |
| US7202259B2 (en) * | 2002-11-18 | 2007-04-10 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| SA04250305B1 (ar) | 2003-09-25 | 2008-06-02 | سولفاي فارماسوتيكالز بي . في | مشتقات بنزيميدازولون cenzimidazolone وكينازولينون quinazolinone كمساعادات على مستقبلات ORL1 البشرية |
| AR045843A1 (es) * | 2003-10-03 | 2005-11-16 | Solvay Pharm Bv | Derivados de bencimidazolonas y quinazolinonas sustituidas con hidronopol como agonistas en receptores orl 1 humanos |
| WO2005075455A2 (en) | 2004-01-30 | 2005-08-18 | Euro-Celtique S.A. | Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
| KR20070012675A (ko) * | 2004-04-20 | 2007-01-26 | 사노피-아벤티스 | 메틸(+)-(S)-α-(2-클로로페닐)-6,7-디히드로티에노[3,2-C]피리딘-5(4H) 아세테이트 히드로브로마이드, 클로피도그렐히드로브로마이드의 다형성 형태 |
| AR054816A1 (es) * | 2005-07-13 | 2007-07-18 | Banyu Pharma Co Ltd | Derivados de n-dihidroxialquil 2-oxo- imidazol sustituidos |
| US7300947B2 (en) * | 2005-07-13 | 2007-11-27 | Banyu Pharmaceutical Co., Ltd. | N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives |
| EP1935881B1 (de) * | 2005-09-30 | 2012-04-04 | Msd K.K. | Arylsubstituierte, stickstoffhaltige heterocyclische verbindung |
| WO2007050381A2 (en) * | 2005-10-24 | 2007-05-03 | Janssen Pharmaceutica, N.V. | 3-piperidin-4-yl-indole orl-1 receptor modulators |
| JP2009525269A (ja) * | 2006-01-30 | 2009-07-09 | ユーロ−セルティーク エス.エイ. | カルシウムチャネルブロッカーとしての環状尿素化合物 |
| GB0605784D0 (en) * | 2006-03-22 | 2006-05-03 | Glaxo Group Ltd | Compounds |
| GB0605786D0 (en) * | 2006-03-22 | 2006-05-03 | Glaxo Group Ltd | Compounds |
| US8775704B2 (en) * | 2006-04-05 | 2014-07-08 | Nvidia Corporation | Method and system for communication between a secondary processor and an auxiliary display subsystem of a notebook |
| DE102006046745A1 (de) * | 2006-09-29 | 2008-04-03 | Grünenthal GmbH | Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz |
| EP2397477B1 (de) * | 2007-01-16 | 2014-03-05 | Purdue Pharma LP | Heterocyclisch-substituierte Piperidinverbindungen und Verwendungen davon |
| RU2451017C2 (ru) * | 2007-03-01 | 2012-05-20 | Мицубиси Танабе Фарма Корпорейшн | Бензимидазольное соединение и его фармацевтическое применение |
| CN101622241B (zh) * | 2007-03-01 | 2013-05-22 | 田边三菱制药株式会社 | 苯并咪唑化合物及其医药用途 |
| WO2009027820A2 (en) | 2007-08-31 | 2009-03-05 | Purdue Pharma L.P. | Substituted-quinoxaline-type-piperidine compounds and the uses thereof |
| WO2009124883A1 (en) * | 2008-04-09 | 2009-10-15 | H. Lundbeck A/S | Novel 1,3-dihydro-benzoimidazol-2-ones as m1 agonists |
| RS52590B2 (sr) | 2008-07-21 | 2018-05-31 | Purdue Pharma Lp | Jedinjenja tipa supstituisanog hinoksalina sa premošćenim piperidinom i njihova upotreba |
| US8736617B2 (en) * | 2008-08-04 | 2014-05-27 | Nvidia Corporation | Hybrid graphic display |
| TW201016675A (en) | 2008-09-16 | 2010-05-01 | Mitsubishi Tanabe Pharma Corp | Crystalline benzoimidazole compound and salt thereof |
| US9075559B2 (en) * | 2009-02-27 | 2015-07-07 | Nvidia Corporation | Multiple graphics processing unit system and method |
| US9135675B2 (en) * | 2009-06-15 | 2015-09-15 | Nvidia Corporation | Multiple graphics processing unit display synchronization system and method |
| US8766989B2 (en) * | 2009-07-29 | 2014-07-01 | Nvidia Corporation | Method and system for dynamically adding and removing display modes coordinated across multiple graphics processing units |
| US9111325B2 (en) * | 2009-12-31 | 2015-08-18 | Nvidia Corporation | Shared buffer techniques for heterogeneous hybrid graphics |
| US8780122B2 (en) * | 2009-09-16 | 2014-07-15 | Nvidia Corporation | Techniques for transferring graphics data from system memory to a discrete GPU |
| US9951038B2 (en) | 2012-12-27 | 2018-04-24 | Purdue Pharma L.P. | Quinazolin-4(3H)-one-type piperidine compounds and uses thereof |
| US9090618B2 (en) | 2012-12-27 | 2015-07-28 | Purdue Pharma L.P. | Substituted benzimidazole-type piperidine compounds and uses thereof |
| US10118927B2 (en) | 2012-12-27 | 2018-11-06 | Purdue Pharma L.P. | Substituted piperidin-4-amino-type compounds and uses thereof |
| US9963458B2 (en) | 2012-12-27 | 2018-05-08 | Purdue Pharma L.P. | Indole and indoline-type piperidine compounds and uses thereof |
| US9818379B2 (en) | 2013-08-08 | 2017-11-14 | Nvidia Corporation | Pixel data transmission over multiple pixel interfaces |
| EP4353713A4 (de) * | 2021-06-07 | 2025-09-03 | Univ Kinki | T-calciumkanalblocker |
| AU2025206007A1 (en) * | 2024-01-05 | 2026-04-16 | Yichang Humanwell Pharmaceutical Co., Ltd. | Cyclohexyl-substituted piperidine derivative, pharmaceutical composition comprising same, and use thereof |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE633495A (de) * | 1962-06-13 | |||
| US3161645A (en) | 1962-12-18 | 1964-12-15 | Res Lab Dr C Janssen N V | 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds |
| US3318900A (en) * | 1964-05-06 | 1967-05-09 | Janssen Pharmaceutica Nv | Derivatives of benzimidazolinyl piperidine |
| GR69650B (de) * | 1978-07-20 | 1982-07-07 | Science Union & Cie | |
| US4329353A (en) * | 1980-10-22 | 1982-05-11 | Janssen Pharmaceutica, N.V. | 1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof |
| JPS58180481A (ja) | 1982-04-15 | 1983-10-21 | Kyowa Hakko Kogyo Co Ltd | 新規なピペリジン誘導体 |
| US6150355A (en) | 1995-09-13 | 2000-11-21 | Kyowa Hakko Kogyo Co., Ltd. | Phenylpiperidine derivative |
| DE69736776T2 (de) * | 1996-04-19 | 2007-01-18 | Neurosearch A/S | 1-(4-piperidyl)-benzimidazole mit neurotropher aktivität |
| CA2291094C (en) | 1997-05-30 | 2008-02-26 | Banyu Pharmaceutical Co., Ltd. | 2-oxoimidazole derivative |
| SI0921125T1 (en) | 1997-12-05 | 2002-04-30 | F. Hoffmann-La Roche Ag | 1,3,8-Triazaspiro(4,5)decan-4-on derivatives |
| US6166209A (en) | 1997-12-11 | 2000-12-26 | Hoffmann-La Roche Inc. | Piperidine derivatives |
| US6626939B1 (en) | 1997-12-18 | 2003-09-30 | Boston Scientific Scimed, Inc. | Stent-graft with bioabsorbable structural support |
| PL342046A1 (en) * | 1998-01-19 | 2001-05-21 | Pfizer | 4-(2-keto-1-benzimidazolinyl)piperidine compounds as agonists of orl1 receptor |
| NZ507760A (en) | 1998-03-26 | 2002-10-25 | Japan Tobacco Inc | Amide derivatives and nociceptin antagonists |
| JP2002515503A (ja) | 1998-05-18 | 2002-05-28 | ノボ ノルディスク アクティーゼルスカブ | オピオイド受容体のサブタイプへの高い親和性を有する新規1,3,8−トリアザスピロ〔4,5〕デカノン |
| US6262066B1 (en) * | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| ID29137A (id) * | 1998-07-27 | 2001-08-02 | Schering Corp | Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1 |
| JP2003524634A (ja) * | 1999-12-06 | 2003-08-19 | ユーロ−セルティーク,エス.エイ. | ノシセプチン受容体親和性を有するベンズイミダゾール化合物 |
-
2000
- 2000-12-06 JP JP2001541507A patent/JP2003524634A/ja active Pending
- 2000-12-06 AT AT00980981T patent/ATE302770T1/de not_active IP Right Cessation
- 2000-12-06 WO PCT/US2000/033019 patent/WO2001039775A1/en not_active Ceased
- 2000-12-06 AU AU18169/01A patent/AU1816901A/en not_active Abandoned
- 2000-12-06 EP EP00980981A patent/EP1242085B1/de not_active Expired - Lifetime
- 2000-12-06 DE DE60022226T patent/DE60022226D1/de not_active Expired - Lifetime
- 2000-12-06 US US09/730,934 patent/US7456198B2/en not_active Expired - Lifetime
- 2000-12-06 HK HK03101335.9A patent/HK1049284B/en not_active IP Right Cessation
-
2006
- 2006-07-28 US US11/494,826 patent/US7678809B2/en not_active Expired - Fee Related
-
2007
- 2007-06-15 JP JP2007158916A patent/JP2007277257A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1242085A1 (de) | 2002-09-25 |
| HK1049284B (en) | 2006-02-24 |
| US7456198B2 (en) | 2008-11-25 |
| EP1242085A4 (de) | 2003-02-12 |
| US20060264638A1 (en) | 2006-11-23 |
| US7678809B2 (en) | 2010-03-16 |
| DE60022226D1 (de) | 2005-09-29 |
| AU1816901A (en) | 2001-06-12 |
| US20020128288A1 (en) | 2002-09-12 |
| JP2003524634A (ja) | 2003-08-19 |
| HK1049284A1 (en) | 2003-05-09 |
| EP1242085B1 (de) | 2005-08-24 |
| WO2001039775A1 (en) | 2001-06-07 |
| JP2007277257A (ja) | 2007-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60022226D1 (de) | Benzimidazolverbindungen die nociceptinrezeptoraffinität haben | |
| NO20013444D0 (no) | Triazolforbindelser med dopamin-D3-reseptor-affinet | |
| ATE314371T1 (de) | Spiro-indole als y5-rezeptor antagonisten | |
| DE60332137D1 (en) | Cyclohexyl-sulphone als gamma-sekretase-inhibitoren | |
| SE9900100D0 (sv) | New compounds | |
| DE69925133D1 (de) | Pyrrolobenzodiazepine | |
| ECSP045081A (es) | Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados | |
| TR199801255T2 (xx) | Vitronektin resept�r antagonistleri. | |
| DK1200412T3 (da) | Antiproliferative imidazolforbindelser | |
| DE60216233D1 (en) | Carbolinderivate | |
| AU2002246728A1 (en) | Carboline derivatives | |
| ATE304530T1 (de) | Substituierte 1,5-dihydropyrrol-2-on-derivate wirksam als nmda-rezeptor-antagonisten für die behandlung von schmerzzuständen | |
| TR200102178T2 (tr) | CRF reseptör antagonistleri ve bunlarla ilgili yöntemler. | |
| EA200200742A1 (ru) | 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии | |
| WO2001039723A3 (en) | Triazospiro compounds having nociceptin receptor affinity | |
| TR200201245T2 (tr) | Kanser tedavisi için onkolitik kombinasyonlar. | |
| DE60115466D1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
| DE60317675D1 (de) | KRYSTALLINE 2,5-DIONE-3-(1-METHYL-1H-INDOL-3-YL)-4-i1-(PYRIDIN-2-YLMETHYL)PIPERIDIN-4-YL -1H-INDOL-3-YL -1H-PYRROLE MONO-HYDROCHLORIDE | |
| AR022321A1 (es) | Derivados de anticonvulsivo utiles para el tratamiento de la migrana transformada | |
| DK1305037T3 (da) | Smertestillende medikament | |
| EE200300129A (et) | Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine | |
| TR200103125T2 (tr) | Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri. | |
| EP1572129A4 (de) | Amidin-derivate zur behandlung von amyloidose | |
| ATE232081T1 (de) | Orale zusammensetzung enthaltend perlit | |
| DE502004007387D1 (de) | Triazolverbindungen und ihre therapeutische verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |